Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 10;401(10392):1909-1912.
doi: 10.1016/S0140-6736(23)01012-7. Epub 2023 May 22.

No time for complacency on COVID-19 in Europe

Antoine Flahault  1 , Alexandra Calmy  2 , Dominique Costagliola  3 , Oxana Drapkina  4 , Isabella Eckerle  5 , Heidi J Larson  6 , Helena Legido-Quigley  7 , Catherine Noakes  8 , Michel Kazatchkine  9 , Hans Kluge  10
Affiliations

No time for complacency on COVID-19 in Europe

Antoine Flahault et al. Lancet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

AF is Chair of and AC, DC, OD, IE, HJL, HL-Q, CN, and MK are members of the High-Level Expert Group for COVID-19 that has advised Hans Kluge since 2021. HK is the Regional Director of the WHO Regional Office for Europe. AC report grants from ViiV Healthcare, Gilead Sciences, and MSD and is the principal investigator of the OPTICOV trial. DC report institutional grant from Janssen and honoraria for lectures from Gilead and Pfizer. HJL reports grants from GSK, Merck, and a MacArthur Award for the Vaccine Confidence Project and honoraria for lectures from UNC and NYU. HL-Q was a member of the Secretariat of the Independent Panel for Pandemic Preparedness and Response. CN reports grants from the Engineering and Physical Sciences Research Council, the UK Department of Health and Social Care, the Natural Environment Research Council, NHS Scotland, and the UK Government for various projects on transmission of COVID-19; is a member of the UK Government SAGE Committee, Co-Chair of SAGE Environment and Modelling group, is a member of multiple UK and Scottish Government and NHS working groups on COVID-19, is a member of WHO ECAP, and a member of the Royal Academy of Engineering and Academy of Medical Sciences working groups on COVID-19 mitigation. MK is an independent Board member of ExevirBio, a biotechnology company designing therapeutic monoclonal antibodies against SARS Cov2. We declare no other competing interests. We thank Catherine Smallwood, Gerald Rockenschaub, and Richard Pebody, from the WHO Regional Office for Europe, for their participation in reviewing and their helpful contributions to this Comment.

References

    1. WHO Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. May 5, 2023. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meet...
    1. Lenharo M. WHO declares end to COVID-19's emergency phase. Nature. 2023 doi: 10.1038/d41586-023-01559-z. published online May 5. - DOI - PubMed
    1. Gavenčiak T, Monrad JT, Leech G, et al. Seasonal variation in SARS-CoV-2 transmission in temperate climates: a Bayesian modelling study in 143 European regions. PLoS Comput Biol. 2022;18 - PMC - PubMed
    1. EuroMOMO EuroMOMO Bulletin, week 17, 2023. 2023. https://www.euromomo.eu/
    1. Our World in Data Coronavirus (COVID-19) deaths. 2023. https://ourworldindata.org/covid-deaths